1. Home
  2. NPCE vs PSNL Comparison

NPCE vs PSNL Comparison

Compare NPCE & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.31

Market Cap

623.0M

Sector

Health Care

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$7.90

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
PSNL
Founded
1997
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
623.0M
729.1M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
NPCE
PSNL
Price
$16.31
$7.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$18.33
$12.20
AVG Volume (30 Days)
199.4K
2.3M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
33.58
EPS
N/A
N/A
Revenue
$99,986,000.00
$69,648,000.00
Revenue This Year
$0.90
$15.34
Revenue Next Year
$24.46
$41.46
P/E Ratio
N/A
N/A
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$3.84
52 Week High
$19.60
$11.50

Technical Indicators

Market Signals
Indicator
NPCE
PSNL
Relative Strength Index (RSI) 50.13 67.74
Support Level $15.17 $7.74
Resistance Level $17.04 $9.64
Average True Range (ATR) 1.17 0.56
MACD -0.24 0.23
Stochastic Oscillator 42.86 99.01

Price Performance

Historical Comparison
NPCE
PSNL

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: